Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience
Pharmaceuticals · 10.05.2024 · 17 (5) · 612
DOI: 10.3390/ph17050612 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 10.05.2024. Verfasst von Evridiki Asimakidou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK. Die Arbeit wurde bisher 114-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Presidential Postdoctoral Fellowship, Lee Kong Chian School of Medicine Dean's Postdoctoral Fellowship, Nanyang Technological University (NTU) Singapore.
Abstract (Originalsprache)
Overcoming the blood–brain barrier (BBB) remains a significant hurdle in effective drug delivery to the brain. While the BBB serves as a crucial protective barrier, it poses challenges in delivering therapeutic agents to their intended targets within the brain parenchyma. To enhance drug delivery for the treatment of neurological diseases, several delivery technologies to circumvent the BBB have been developed in the last few years. Among them, nanoparticles (NPs) are one of the most versatile and promising tools. Here, we summarize the characteristics of NPs that facilitate BBB penetration, including their size, shape, chemical composition, surface charge, and importantly, their conjugation with various biological or synthetic molecules such as glucose, transferrin, insulin, polyethylene glycol, peptides, and aptamers. Additionally, we discuss the coating of NPs with surfactants. A comprehensive overview of the common in vitro and in vivo models of the BBB for NP penetration studies is also provided. The discussion extends to discussing BBB impairment under pathological conditions and leveraging BBB alterations under pathological conditions to enhance drug delivery. Emphasizing the need for future studies to uncover the inherent therapeutic properties of NPs, the review advocates for their role beyond delivery systems and calls for efforts translating NPs to the clinic as therapeutics. Overall, NPs stand out as a highly promising therapeutic strategy for precise BBB targeting and drug delivery in neurological disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Neurosciences, University of Cambridge, Cambridge CB2 0QQ, UK.
- Department of Biomedical Engineering, College of Design and Engineering, National University of Singapore, Singapore 117575, Singapore.
- The N.1 Institute for Health, National University of Singapore, Singapore 117456, Singapore.
- Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore 308232, Singapore.
ORCID-Profile: Justin Kok Soon Tan, Jialiu Zeng
Förderung
- Presidential Postdoctoral Fellowship
- Lee Kong Chian School of Medicine Dean's Postdoctoral Fellowship
- Nanyang Technological University (NTU) Singapore
Zitieren
APA
Asimakidou, E., Tan, J. K. S., Zeng, J., & Lo, C. H. (2024). Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience. Pharmaceuticals, 17(5), 612. https://doi.org/10.3390/ph17050612
Vancouver
Asimakidou E, Tan JKS, Zeng J, Lo CH. Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience. Pharmaceuticals. 2024;17(5):612. doi:10.3390/ph17050612
BibTeX
@article{Asimakidou2024,
author = {Asimakidou, Evridiki and Tan, Justin Kok Soon and Zeng, Jialiu and Lo, Chih Hung},
title = {Blood–Brain Barrier-Targeting Nanoparticles: Biomaterial Properties and Biomedical Applications in Translational Neuroscience},
journal = {Pharmaceuticals},
year = {2024},
volume = {17},
number = {5},
pages = {612},
doi = {10.3390/ph17050612}
}
EUVIMED